H. Edward Fleming, Jr., M.D.
Dr. Edd Fleming has served on our Board of Directors since June 2021. Dr. Fleming is a Senior Partner at McKinsey, serving as global leader of their R&D practice. He joined McKinsey in 1997 where he has worked with healthcare companies of all sizes to improve their performance. Dr. Fleming earned his B.A. in Chemistry from Harvard University, his M.D. from Vanderbilt University, and completed internal medicine training at Johns Hopkins Hospital and subspecialty training in pulmonary and critical care medicine at the University of California, San Francisco. Dr. Fleming serves on the Board of Visitors for Vanderbilt’s School of Basic Sciences. We believe Dr. Fleming’s experience in the healthcare industry, including working closely with biopharmaceutical companies on strategy, operational performance and R&D innovation, qualifies him to serve on our Board of Directors.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.